Schedule 13D ownership disclosure
BIOXCEL THERAPEUTICS INC
Security class unavailable · CUSIP: 09075P105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 892,453
- Percent of class
- 4.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-20-001271
- Form type
- SC 13D
- Filer
- BioXcel Therapeutics, Inc.
- CIK
- CIK 1720893
- Filed
- Mar 06, 2020
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership